Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deoulin nebulizer vs combination regimens in hospitalized COPD patients
IRCT20210830052333N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoint: Length of hospital stay. Started Sep 2021; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20210830052333N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210830052333N1.